
WASHINGTON, Oct. 19 (UPI) -- The U.S. Food and Drug Administration says it has approved the use of the vaccine Gardasil to prevent male genital warts due to the human papillomavirus.
The FDA said it approved Gardasil (condyloma acuminata) to stop warts caused by HPV in boys and men ages 9-26 years. Genital warts are diagnosed annually in approximately 2 of every 1,000 men in the United States, the federal agency said.
The FDA previously approved Gardasil for use in girls and women ages 9-26 for the prevention of cervical, vulvar and vaginal cancer caused by HPV, as well as pre-cancerous lesions and genital warts.
HPV is the most common sexually transmitted infection in the United States and most genital warts are caused by HPV infection.
"This vaccine is the first preventive therapy against genital warts in boys and men ages 9 through 26, and, as a result, fewer men will need to undergo treatment for genital warts," said Dr. Karen Midthun, acting director of the FDA's Center for Biologics Evaluation and Research.
Gardasil is manufactured by Merck and Company Inc. of Whitehouse Station, N.J.
|
|
|
| Additional Science News Stories | |
TACOMA, Wash., Feb. 9 (UPI) --
The mother of Josh Powell, who killed himself and his sons in a fire in Washington state, said in divorce papers he exhibited disturbing behavior as a teenager.
|
NEW YORK, Feb. 9 (UPI) --
Macaulay Culkin is in "perfectly good health," his publicist said after the former child star was photographed looking gaunt and disheveled in New York.
|
GREENBELT, Md., Feb. 9 (UPI) --
NASA's Mars Reconnaissance Orbiter has captured the first color image from orbit of the three-petal lander of NASA's 2004 Rover Spirit mission, scientists say.
|
XINXIANG CITY, China, Feb. 9 (UPI) --
A set of parents in China said they expected a large baby, but they were shocked when their son came out weighing a potentially record-setting 15 1/2 pounds.
|
| Stories | Photos | People | Comments |
View Caption